tweenvest

Alebund Pharmaceuticals (Jiangsu) Limited (SEHK: 9637)

Health Care · Pharmaceuticals · CN

HK$20.60

-2.92% today · -55.2% 1Y

Public summary
A free snapshot of Alebund Pharmaceuticals (Jiangsu) Limited, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Alebund Pharmaceuticals (Jiangsu) Limited (SEHK: 9637) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $892.36M.

Over the last twelve months the share price has lost 55.2%, trading between 14.36 and 46.82.

Tweenvest scores Alebund Pharmaceuticals (Jiangsu) Limited across four factors: quality 43/100, value 67/100. Its strongest factor is value.

9637 price history

Jul 3, 2026 · 30.28Weekly closes 15.59 – 33.48Nov 13, 2026 · 20.60

Key figures

Market cap
$892.36M
Revenue (TTM)
$18.05M
P/E
-19.69
EPS
-3.42
Dividend yield
—
Beta (5Y)
—
52-week high
HK$46.82
52-week low
HK$14.36
Avg volume (3M)
—
Shares outstanding
339.85M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Northeast Pharmaceutical Group Co., Ltd.SZSE: 000597$914.93MCN¥4.28-2.28%
Kaken Pharmaceutical Co., Ltd.TSE: 4521$905.97M¥3,825.00-0.39%
Wanbangde Pharmaceutical Holding Group Co., Ltd.SZSE: 002082$895.30MCN¥9.77-3.46%
Sihuan Pharmaceutical Holdings Group Ltd.SEHK: 460$894.37MHK$0.78-1.89%
GuangYuYuan Chinese Herbal Medicine Co., Ltd.SHSE: 600771$886.49MCN¥12.09-2.11%
Dezhan Healthcare Company LimitedSZSE: 000813$879.67MCN¥2.80-2.78%
Hunan Warrant Pharmaceutical Co.,LtdSHSE: 688799$875.28MCN¥43.72-6.14%
Latigo Biotherapeutics, Inc.NasdaqGS: LTGO$869.18M$13.11+1.39%

Browse every Pharmaceuticals company →